Pharmabiomed News

07/13/2022

Novel Factor XI Inhibitor Fast Tracked for Thrombosis Associated With Cancer

Learn more ->

Abelacimab is a highly selective, fully human monoclonal antibody designed to inhibit both factor XI and its activated form, factor XIa.

07/13/2022

Low Risk Seen for Health Care-Linked Monkeypox Transmission

Learn more -> https://www.empr.com/home/news/low-risk-seen-for-health-care-linked-monkeypox-transmission/

06/15/2022

FDA Clears Device to Assist in Earlier Diagnosis of Autism Spectrum Disorder

Learn more -> https://www.empr.com/home/news/fda-clears-device-to-assist-in-earlier-diagnosis-of-autism-spectrum-disorder/

06/01/2022

Evrysdi Use Extended to Infants Younger Than 2 Months With Spinal Muscular Atrophy

Learn more -> https://www.empr.com/home/news/evrysdi-use-extended-to-infants-younger-than-2-months-with-spinal-muscular-atrophy/

05/20/2022

Wearable TENS Device Cleared for Fibromyalgia Treatment

Learn more -> https://www.empr.com/home/news/wearable-tens-device-cleared-for-fibromyalgia-treatment/

04/28/2022

Asthma, Atopy Risks Up in Offspring Born Via Infertility Treatment

Learn more ->

Long-term follow-up of children shows increased asthma/allergy risk, independent of parental history of asthma and atopy

04/21/2022

CDC Launches Forecasting Center for Infectious Diseases

Learn more -> https://www.empr.com/home/news/cdc-launches-forecasting-center-for-infectious-diseases/

04/12/2022

Investigational Oral Therapy Fast Tracked for Familial Adenomatous Polyposis

Learn more -> https://www.empr.com/home/news/drugs-in-the-pipeline/investigational-oral-therapy-fast-tracked-for-familial-adenomatous-polyposis/

03/31/2022

Managing Glycemia in Children with Type 1 Diabetes

Learn more -> https://www.nejm.org/doi/full/10.1056/NEJMcp2112175?query=featured_home

03/29/2022

Cabenuva Label Update Makes Oral Lead-In Dosing Optional

Learn more -> https://www.empr.com/home/news/cabenuva-label-update-makes-oral-lead-in-dosing-optional/